Centene logged a -0.2% change during today's evening session, and is now trading at a price of $74.24 per share. The S&P 500 index moved 1.0%. CNC's trading volume is 2,268,001 compared to the stock's average volume of 3,104,220.
Centene trades -11.12% away from its average analyst target price of $83.53 per share. The 15 analysts following the stock have set target prices ranging from $72.0 to $110.0, and on average have given Centene a rating of buy.
Anyone interested in buying CNC should be aware of the facts below:
-
Centene's current price is 0.1% above its Graham number of $74.19, which implies that at its current valuation it does not offer a margin of safety
-
Centene has moved -14.0% over the last year, and the S&P 500 logged a change of 17.0%
-
Based on its trailing earnings per share of 4.51, Centene has a trailing 12 month Price to Earnings (P/E) ratio of 16.5 while the S&P 500 average is 15.97
-
CNC has a forward P/E ratio of 11.0 based on its forward 12 month price to earnings (EPS) of $6.77 per share
-
The company has a price to earnings growth (PEG) ratio of 0.88 — a number near or below 1 signifying that Centene is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 1.57 compared to its sector average of 4.08
-
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States.
-
Based in Saint Louis, the company has 74,300 full time employees and a market cap of $39.66 Billion.